Quantitative Estimation of Roxithromycin and Ambroxol in Bulk and Tablet Dosage Forms by RP-HPLC Method

 

K. Umadevi1*, Mohibul Hoque1, Ramya Sri. S2

1Department of Pharmaceutical Analysis, Samskruti College of Pharmacy,

Affiliated to JNTUH University, Hyderabad 501301, Telangana, India.

2Department of Pharmacy, University College of Technology, Osmania University,

Hyderabad, Telangana, 500007, India.

*Corresponding Author E-mail: umadevianalysis@gmail.com

 

Abstract:

A Rapid and Precise Reverse Phase High Performance Liquid Chromatographic method has been developed for the validated of Roxithromycin and Ambroxol, in its pure form as well as in tablet dosage form. Chromatography was carried out on Altima C18 (4.6 x 150mm, 5µm) column using a mixture of ACN, Methanol and Phosphate buffer pH4.6 (10:25:65 v/v) as the mobile phase at a flow rate of 1.0ml/min, the detection was carried out at 215nm. The retention time of the Roxithromycin and Ambroxol was 2.344, 3.286±0.02min respectively. The method produce linear responses in the concentration range of 10-50mg/ml of Roxithromycin and 2.5-12.5mg/ml of Ambroxol. The method precision for the determination of assay was below 2.0 %RSD. The method is useful in the quality control of bulk and pharmaceutical formulations.

 

KEYWORDS: Roxithromycin, Ambroxol, RP-HPLC, Validation.

 

 


INTRODUCTION:

Analytical chemistry plays a vital role in maintaining the quality of drugs. It consists of Qualitative and Quantitative estimations1. To develop a new HPLC method for any drug, knowledge of its molecular weight, polarity, ionic character, pKa values, wavelength of absorption, purity of compound and the solubility should be known. Method development involves considerable effort and time.2

 

Acute respiratory infections (ARI) may cause inflammation of the respiratory tract anywhere from nose to alveoli, with a wide range of combination of symptoms and signs. ARI is often classified by clinical syndromes depending on the site of infection and is referred to as ARI of upper (AURI) or lower (ALRI) respiratory tract.3 Upper respiratory tract comprises of the airways from nostrils to the vocal cords in the larynx, plus the paranasal sinuses and the middle ear. Upper respiratory tract infection (URTI) includes the common cold, laryngitis, pharyngitis/tonsillitis, acute rhinitis and acute otitis media. The lower respiratory tract includes the furtherance of the airways from the trachea and bronchi to the bronchioles and the alveoli. Lower respiratory tract infection (LRTI) includes acute bronchitis, bronchiolitis and pneumonia4.

 

WHO reported more than four million deaths a year from acute respiratory infections in the developing world quarters. Mortality may be greater in developing countries because of low resistance of children due to malnutrition, overcrowding and poor environmental circumstances such as indoor air pollution5. Respiratory problems are responsible for a large proportion of pediatric admissions and outpatient attendance. Children are an embodiment of our dreams and hopes of the future.6

 

 

Roxithromycin macrolide category wide spectrum antibacterial drug that inhibits bacterial protein biosynthesis by binding reversibly to the subunit 50S of the bacterial ribosome, thereby inhibiting translocation of peptidyl-Trna7. It acts on gram-positive and gram-negative bacteria. It is used to treat respiratory tract, urinary and soft tissue infections. ROX is derived from erythromycin, containing the same 14-membered lactone ring8.

 

ROX is erythromycin 9-[O-[(2)-methoxyethoxy) methyl] oxime, a semi synthetic macrolide antibiotic drug, very slightly soluble in water and aqueous fluids and its absorption is dissolution rate limited. ROX is used in the treatment of UTI, RTI, ENT, genital tract, skin and soft tissue infections9.

 

Fig 1: Chemical Structure of Roxithromycin10

 

Ambroxol is an expectorant useful in the treatment of bronchial asthma and chronic bronchitis.  Moreover, it exhibits antioxidant and anti-inflammatory properties.11

 

Ambroxol hydrochloride is metabolite of bromhexine and it is administered as hydrochloride salt. It is used in a variety of disorders including chronic bronchitis, cystic fibrosis and infant’s respiratory disorder syndrome. Chemically it is trans-4-{(2-amino-3, 5-dibromobenzyl) amino} cyclohexanol hydrochloride. Literature survey reveals HPLC, RP-HPLC and UV-spectrophotometric method for determination of ambroxol hydrochloride in tablets12.

 

It is an expectoration improver and a mucolytic agent used in the treatment of acute and chronic disorders characterized by the production of excess or thick mucous. It has been successfully used for decades in the form of its hydrochloride as a secretion-releasing expectorant in a variety of respiratory disorders13.

 

It stimulates the transportation of the viscous secretions in the respiratory organs and reduces the stand stillness of the secretions. It is official in IP1. Few methods have been reported in the literature for the determination of AMBRO individually or in combination with other drugs14.

 

Fig 2: Chemical Structure of Ambroxol15

 

MATERIALS AND METHODS:

Roxithromycin (Pure) from Sura labs, Ambroxol (Pure) from Sura labs, Water and Methanol for HPLC from LICHROSOLV (MERCK), Acetonitrile for HPLC from Merck.

 

HPLC METHOD DEVELOPMENT:

TRAILS:

Preparation of standard solution:

Accurately weigh and transfer 10mg of Roxithromycin and Ambroxol working standard into a 10ml of clean dry volumetric flasks add about 7ml of Methanol and sonicate to dissolve and removal of air completely and make volume up to the mark with the same Methanol.

 

Pipette out 0.3ml of Roxithromycin and 0.75ml of Ambroxol stock solutions was take in a 10ml of volumetric flask dilute up to the mark with diluent.

 

Procedure:

Inject the samples by changing the chromatographic conditions and record the chromatograms, note the conditions of proper peak elution for performing validation parameters as per ICH guidelines.

 

Mobile Phase Optimization:

Initially the mobile phase tried was Methanol: Orthophosphoric acid and Phosphoric acid (pH 3): Acetonitrile and Methanol: ACN with varying proportions. Finally, the mobile phase was optimized to Buffer: Methanol: ACN in proportion 65:25:10v/v respectively. 

 

Optimization of Column:

The method was performed with various C18 columns like ODS and Zodiac column. Altima C18 (4.6×150mm, 5µ) was found to be ideal as it gave good peak shape and resolution at 1ml/min flow.

 

Validation methods procedures followed as per ICH guidelines.

 

RESULTS AND DISCUSSION:

Optimized Chromatogram (Standard):

Mobile phase           :   Buffer: Methanol: ACN (65:25:10v/v)

Column                    :   Altima C18 (4.6×150mm, 5.0 µm)

Flow rate                  :   1ml/min

Wavelength              :   215nm

Column temp           :  38ŗC

Injection Volume     :  10µl

Run time                   :  5 minutes

 

Fig 3: Optimized Chromatogram

 

Table 1: - peak results for optimised

S. No

Peak name

Rt

Area

Height

USP Resolution

USP Tailing

USP plate count

1

Ambroxol

2.488

1308595

247456

 

1.2

5835.5

2

Roxithromycin

4.866

124505

19187

6.0

1.1

5745.2

 

Optimized Chromatogram (Sample)

 

Figure 4: Optimized Chromatogram (Sample)

 

Table 2: Optimized Chromatogram (Sample)

S. No

Peak name

Rt

Area

Height

USP Resolution

USP Tailing

USP plate count

1

Ambroxol

2.487

1307139

246586

 

1.2

5565.5

2

Roxithromycin

4.865

124452

19117

6.0

1.1

5355.2

 

Assay (Standard):

Table 3: Peak results for assay standard

S. No.

Name

Rt

Area

Height

USP Resolution

USP Tailing

USP plate count

Injection

1

Ambroxol

2.488

1308945

247282

 

1.3

5568.0

1

2

Roxithromycin

4.838

124336

19189

6.0

1.2

5359.2

1

3

Ambroxol

2.492

1309481

247456

 

1.0

5565.5

2

4

Roxithromycin

4.846

124505

19187

6.0

1.3

5355.2

2

5

Ambroxol

2.493

1317926

247578

 

1.0

5545.5

3

6

Roxithromycin

4.844

124903

19210

6.0

1.3

5352.1

3

 

Assay (Sample):

Table 4: Peak results for Assay sample

S. no.

Name

Rt

Area

Height

USP Resolution

USP Tailing

USP plate count

Injection

1

Ambroxol

2.494

1307139

246586

 

1.3

6568.0

1

2

Roxithromycin

4.840

124452

19117

6.0

1.1

5359.2

1

3

Ambroxol

2.491

1308903

248422

 

1.3

5565.5

2

4

Roxithromycin

4.842

124632

19178

6.0

1.2

5355.2

2

5

Ambroxol

2.491

1325993

248924

 

1.3

5391.1

3

6

Roxithromycin

4.834

126697

19237

6.0

1.2

5564.0

3

 

%ASSAY =

  Sample area        Weight of standard     Dilution of sample     Purity      Weight of tablet

 ___________ ×   ________________ × _______________×_______×______________×100

  Standard area      Dilution of standard    Weight of sample       100          Label claim

 

The % purity of Ambroxol and Roxithromycin in pharmaceutical dosage form was found to be 100.3%.

 

LINEARITY:

Chromatographic Data for Linearity Study:

Ambroxol:

 

Concentration Level (%)

Concentration mg/ml

Average  Peak Area

33.3

2.5

47510

66.6

5

85701

100

7.5

124802

133.3

10

162731

166.6

12.5

199732

 

Figure 5: calibration graph for Ambroxol

 

Roxithromycin:

Concentration Level (%)

Concentration mg/ml

Average Peak Area

33

10

518934

66

20

956781

100

30

1413873

133

40

1863458

166

50

2267084

 

Figure 6: calibration graph for Roxithromycin

 

ACCURACY:

Table 6: The accuracy results for Ambroxol

%Concentration

(at specification Level)

Area

Amount Added

(ppm)

Amount Found

(ppm)

% Recovery

Mean Recovery

50%

716072.7

15

14. 9

99.3

99.6%

100%

1404258

30

30.1

100.3

150%

2064609

45

44.7

99.3

                                                                               

Table 7: The accuracy results for Roxithromycin

%Concentration

(at specification Level)

Area

Amount Added

(ppm)

Amount Found

(ppm)

% Recovery

Mean Recovery

50%

63467

3.75

3.72

100.8

100.4%

100%

124353.3

7.5

7.57

100. 9

150%

178607.7

11.25

11.20

99.5

 

Limit of Detection:

The detection  limit  of  an  individual  analytical  procedure  is  the  lowest  amount  of analyte in a sample which can be detected but not necessarily quantitated as an exact value.

 

LOD= 3.3 × σ / s

Where 

σ = Standard deviation of the response   

S = Slope of the calibration curve

 

RESULT:

Ambroxol:

=3.3 × 16724.53/45217

=1.2µg/ml

 

Roxithromycin:

=3.3 × 662.3965/15811

=0.13µg/ml

 

Limit of Quantitation

The  quantitation  limit  of  an  individual  analytical  procedure  is  the  lowest  amount  of analyte  in  a  sample  which  can  be  quantitatively  determined. 

 

LOQ=10×σ/S

Where 

σ = Standard deviation of the response   

S = Slope of the calibration curve

 

RESULT:

Ambroxol:

=10×16724.53/45217

= 3.6 µg/ml

 

Roxithromycin:

=10 × 662.3965/15811

= 0.41 µg/ml

 

Robustness:

Table 8: Results for Robustness

Parameter used for sample analysis

Peak Area

Retention Time

Theoretical plates

Tailing factor

Actual Flow rate of 1.0 mL/min

1308495

2.344

5568.2

1.3

Less Flow rate of 0.9 mL/min

1300148

2. 244

5922.2

1.2

More Flow rate of 1.1 mL/min

1306476

2.243

5868.8

1.2

Less organic phase

1304520

2.345

5836.2

1.2

More organic phase

1207845

2.344

5282.6

1.1

 

Ambroxol:

Table 9: Results for Robustness

 

Roxithromycin:

Parameter used for sample analysis

Peak Area

Retention Time

Theoretical plates

Tailing factor

Actual Flow rate of 1.0 mL/min

124505

3.286

6098.1

1.2

Less Flow rate of 0.9 mL/min

156550

3.181

5999.1

1.2

More Flow rate of 1.1 mL/min

122702

3.181

5989.2

1.1

Less organic phase

122626

3.278

6387.2

1.1

More organic phase

1207845

3.015

4417

1.1

 

CONCLUSION:

In the present investigation, a simple, sensitive, precise and accurate RP-HPLC method was developed for the quantitative estimation of Roxithromycin and Ambroxol in bulk drug and pharmaceutical dosage forms.

 

This method was simple, since diluted samples are directly used without any preliminary chemical derivatisation or purification steps.

 

Roxithromycin and Ambroxol was freely soluble in ethanol, methanol and sparingly soluble in water.

 

Buffer: Methanol: ACN (65:25:10v/v) was chosen as the mobile phase. The solvent system used in this method was economical.

 

The %RSD values were within 2 and the method was found to be precise.

 

The results expressed in Tables for RP-HPLC method was promising. The RP-HPLC method is more sensitive, accurate and precise compared to the Spectrophotometric methods.

 

This method can be used for the routine determination of Roxithromycin and Ambroxol in bulk drug and in Pharmaceutical dosage forms.

 

ACKNOWLEDGEMENT:

Thе Authors arе thankful to the Management and Principal, Department of Pharmacy, Samskruti College of Pharmacy, Hyderabad, for extending support to carry out the research work. Finally, the authors express their gratitude to the Sura Pharma Labs, Dilsukhnagar, Hyderabad, for providing research equipment and facilities.

 

REFERENCES:

1.        R Anusha Naik, Ajay Kumar D., M. Venkatesh. Method Development and Validation of Taurine and Acetyl Cysteine by Using RP -HPLC Method. Asian J. Res. Pharm. Sci. 2018; 8(4):223-235. doi: 10.5958/2231-5659.2018.00038.3.

2.        Govinda Rao Kamala, Sowjanya Vadrevu, Malipeddi Haripriya. Method Development and Validation for Simultaneous Estimation of Omeprazole and Domperidone by RP-HPLC. Asian J. Pharm. Ana. 5(4): 2015; 195-205. doi: 10.5958/2231-5675.2015.00031.9

3.        Mohd. Yaqub Khan, Maryada Roy, Mohammad Ahmad, Mohammad Imtiyaz Ahmad, Irfan Aziz. A Review- Acute Respiratory Infections- the Forgotten Killer of Children. Asian J. Res. Pharm. Sci. 5(1): Jan.-March 2015; Page 49-54. doi: 10.5958/2231-5659.2015.00008.9

4.        Anaghya V Naik, Hebsiba Joseph, Nidhina Mathew, Sumanth Shetty, Rajesh K S, Bharath Raj KC, Juno J Joel1, Gururaj MP, Nandakumar UP. Drug Prescription Pattern in Paediatric Respiratory Tract Infections. Research J. Pharm. and Tech. 2019; 12(3): 1280-1284. doi: 10.5958/0974-360X.2019.00214.2

5.        Kaushal Patidar. A Study to Assess the Effectiveness of Self Instructional Module on Knowledge Regarding Prevention of Acute Respiratory Tract Infection Among the Mother of Under Five Year Children in Bhandu Village, Mehsana District.. Asian J. Nursing Education and Research. 2018; 8(1): 05-06. doi: 10.5958/2349-2996.2018.00002.2

6.        Nomitha Baby, Chandrashekar M, Sheela Williams. A Comparative Study to Assess the Effect on Respiratory Status of Under Five Children with Lower Respiratory Tract Infection in Prone and Lateral Position in Selected Hospitals at Mysore. Asian J. Nur. Edu. and Research 5(4): Oct.- Dec.2015; Page 537-541. doi: 10.5958/2349-2996.2015.00110.X

7.        Surbhi Choursiya, Arpana Indurkhya. Development and Evaluation of Hard Candy Lozenges Containing Roxithromycin for Treatment of Oral Infection. Asian J. Pharm. Ana. 2020; 10(3):150-154. doi: 10.5958/2231-5675.2020.00027.7

8.        Shilpa Jagtap, Smrutidevi Sonavane, Shrikrishna Baokar, Vinod Pawar, Patil R. N. In Vitro New Dissolution Method for the Evaluation of Roxithromycin using pH 6.0 Phosphate Buffer and Determination of its Content by Validated UV Spectrophotometric Method. Research J. Pharma. Dosage Forms and Tech. 2013; 5(5): 277-281.

9.        K Ravi Sankar, NL Prasanthi, SS Manikiran, N Rama Rao. Effect of Solid Dispersion Technique on Improving the Solubility of Roxithromycin. Research J. Pharma. Dosage Forms and Tech. 2010; 2(2):184-188.

10.     https://go.drugbank.com/structures/DB00778/.

11.     Hisham A. Abbas. Modulation of antibiotic activity against Pseudomonas aeruginosa by N-acetylcysteine, ambroxol and ascorbic acid. Asian J. Res. Pharm. Sci. 2(4): Oct.-Dec. 2012; Page 123-128

12.     Potdar VH, Kuchekar BS, Patil SS. Selective Visible Spectrophotometric Estimation of Ambroxol Hydrochloride in Presence of Cetirizine Hydrochloride in Tablets. Asian J. Research Chem. 2(3): July-Sept. 2009 page 278-279.

13.     Chhotaram Seervi, Kundan Pawar, PN Dhabale, ID Gonjari, Chandrakant Raut, Deepali Gharge. Development and Validation of UV Spectrophotometric Method of Ambroxol Hydrochloride in Bulk and Pharmaceutical Formulation. Asian J. Research Chem. 2(4): Oct.-Dec. 2009 page 547-549.

14.     Sohan S. Chitlange, Sneha R. Tawargeri, Kaushalendra K. Chaturvedi. Simultaneous Determination of Amoxicillin Trihydrate and Ambroxol Hydrochloride in Solid Dosage Form By Spectrophotometric and Stability Indicating RP-HPLC Method. Asian J. Research Chem. 4(6): June, 2011; Page 1025-1030.

15.     https://go.drugbank.com/structures/DB06742/

 

 

Received on 23.10.2022       Modified on 26.11.2022

Accepted on 22.12.2022      ©A&V Publications All right reserved

Research J. Science and Tech. 2023; 15(1):1-7.

DOI: 10.52711/2349-2988.2023.00001